efgartigimod alfa

💊Medication

Generic name

Efgartigimod Alfa And Hyaluronidase (Human Recombinant)

Brand names

Vyvgart Hytrulo

Drug class

Endoglycosidase, Neonatal Fc Receptor Blocker, Neonatal Fc Receptor Blockers

Route

Subcutaneous

Type

Human Prescription Drug

Manufacturer

argenx US

Indications: 1 INDICATIONS AND USAGE VYVGART HYTRULO is indicated for the treatment of adult patients with: generalized myasthenia gravis (gMG) chronic inflammatory demyelinating polyneuropathy (CIDP) VYVGART HYTRULO is a combination of efgartigimod alfa, a neonatal Fc receptor blocker, and hyaluronidase, an… (per FDA label)

• RECRUITING
  A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfaargenx · NCT06298565
• PHASE2RECRUITING
  Efgartigimod for the Treatment of Acute Optic NeuritisAnastasia Vishnevetsky, MD, MPH · NCT06453694

via ClinicalTrials.gov

Wikidata facts

Instance of

antibody

via Wikidata · CC0